NCT03579316: Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 96 taking part
- Started
- 7 Dec 2018
- Primary completion
- 31 Dec 2026
- Arms
- Arm II (olaparib, adavosertib)
- Results
- None posted
- 6 Jul 2018: Trial registered
- 7 Dec 2018: Trial started